​Executive Chairman of the Board 

Janet Campbell

The leader who launched Dominion, created the concept of eon, and assembled the company’s world class team.

Janet Campbell is Executive Chairman of the Board and Founder of Dominion Aesthetic Technologies, Inc., the creator of eon, the world’s first non-contact, no-touch laser body contouring robotic platform device. The target market is focused on one of the fastest-growing aesthetic applications, body contouring. She has assembled a team comprised of some of the world’s leading laser experts who have developed and commercialized multiple laser devices for an array of industries, including the aesthetic market.

Ms. Campbell was the founder and former Chairman and CEO of Seno Medical Instruments, Inc., based in San Antonio. Under her leadership, Seno became the world’s leader in the research, development, and commercialization of opto-acoustics for cancer diagnosis. This technology is the first new functional imaging technology developed in 22 years. Ms. Campbell secured over $100M in investment capital for Seno. As CEO, she oversaw the FDA PMA (pre-market approval) which included the largest diagnostic study conducted in the U.S. Prestigious institutions participated in Seno’s U.S. study including MD Anderson, Cleveland Clinic, Yale and New York Weill Cornell. She secured the CE Mark Approval for European sales. Under her guidance, Seno received numerous local and national recognitions such as the Stars of Satai Award and the Frost & Sullivan Award.

Previously, Ms. Campbell served as President and Chief Operating Officer of InforMedix, Inc., where she commercialized the technology and took the company public. Her knowledge of medical products and market changes positioned her with solid working relationships for emerging and Fortune 500 companies and with the venture capital community including such entities as the Woodlands Venture Fund (The Essex Woodlands), Vanguard Ventures and the Susquehanna Group.

She is a board member of the Texas Business Hall of Fame and a member of the Cosmos Club in Washington, D.C. She was a board member of the Griffith’s Leadership Society for Women at the University of Missouri mentoring young women attending the University. Ms. Campbell believes very strongly in mentoring young talent and practices this in her personal and business life. Human Genome Science appointed her as their board representative to Vascular Genetics Inc., where she was elected Chairman of the Board. While residing in Maryland, she was on the Board of Directors of the High-Tech Council of Maryland Incubator. She is a founding member of the Board of Directors of the Bioscience Committee and the Jewish Federation in Washington, D.C. Ms. Campbell served as a special volunteer and guest researcher for the Office of Technology Transfer for the National Institutes of Health (NIH). She also served as an independent reviewer for NIH grants in the cardiovascular arena.

Ms. Campbell was recognized by the University of Missouri as Alumni of the Year in 2005 from the School of Arts and Science. She was the recipient of the international Gold Stevie Award for Female Entrepreneur of the Year in 2013. The San Antonio Business Journal honored her as CEO of the year in the field of medical devices. She was featured as one of only three CEO’s in The Texas CEO Magazine. She was inducted into the San Antonio Women’s Hall of Fame in 2016. Recently, Dominion filed a patent for the novel design of eon. Her companies have received many patents, this is the first one with her name on it.

Ms. Campbell received her BA from the University of Missouri, Columbia and her MBA in finance from The Johns Hopkins University.

Let's continue the conversation

Complete the form on this page EON by completing this form or directly at 800-979-6801 or email info@dominionaesthetic.com.

Copyright © 2020 Dominion Aesthetic Technologies, Inc. All rights reserved. This material also contains registered trademarks, trade-names and brand names of Dominion Aesthetic Technologies, Inc. and no right or license to use such names and marks is granted.